Lornoxicam - CISMeF

Preferred Label : Lornoxicam;

NCIt definition : An orally bioavailable oxicam and non-steroidal anti-inflammatory drug (NSAID), with analgesic, anti-pyretic, anti-thrombotic and anti-inflammatory activities. Upon oral administration, lornoxicam binds to and inhibits the activity of the cyclooxygenase enzymes (COX) type 1 (COX-1) and type 2 (COX-2). This blocks COX-mediated signaling pathways, which leads to reduced prostaglandin and thromboxane production and decreased pain, fever and inflammation.;

UNII : ER09126G7A;

InChIKey : WLHQHAUOOXYABV-UHFFFAOYSA-N;

CAS number : 70374-39-9;

Chemical formula : C13H10ClN3O4S2;

Détails

Origin ID

C72140;

UMLS CUI

C0055477;

Currated CISMeF NLP mapping
- lornoxicam [MeSH concept]
- lornoxicam [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Lornoxicam (substance) [SNOMED CT concept]
- Product containing lornoxicam (medicinal product) [SNOMED CT concept]
- lornoxicam [ATC Code]
- lornoxicam [MeSH concept]
- lornoxicam [MeSH Supplementary Concept]
Validated automatic mappings to BTNT
- lornoxicam [ATC Code]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]
- NCI Drug Dictionary Terminology [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients